Federal support for host-directed therapeutics will help prepare for future health emergencies

With continued support, HDTs have the potential to become an important tool in both pandemic preparedness and biodefence for Canada and our global partners.

A pedestrian walks past a COVID-19 themed mural outside Ottawa City Hall in January 2021. A new class of host-directed therapeutics could provide protection from both anticipated and unanticipated threats to our population, writes Dr. Par Nijhawan. The Hill Times photograph by Andrew Meade

Opinion

BY PAR NIJHAWAN

August 7, 2023

Trying to predict when avian flu will mutate and cross over to humans, when and where the next coronavirus variant will emerge, or if the Marburg virus (a close cousin of Ebola) will spread significantly beyond its origins in Equatorial Africa are difficult and costly endeav...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy